ES2187576T3 - Conjugado para la induccion de la inmunidad celular. - Google Patents

Conjugado para la induccion de la inmunidad celular.

Info

Publication number
ES2187576T3
ES2187576T3 ES95933299T ES95933299T ES2187576T3 ES 2187576 T3 ES2187576 T3 ES 2187576T3 ES 95933299 T ES95933299 T ES 95933299T ES 95933299 T ES95933299 T ES 95933299T ES 2187576 T3 ES2187576 T3 ES 2187576T3
Authority
ES
Spain
Prior art keywords
conjugated
induction
cellular immunity
conjugate
cellular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95933299T
Other languages
English (en)
Inventor
Wolfgang Willi Deppert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2187576T3 publication Critical patent/ES2187576T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/10011—Arenaviridae
    • C12N2760/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

LA INVENCION TRATA DE UN CONJUGADO, QUE COMPRENDE UN PORTADOR SIN EFECTO INMUNOGENICO Y UN EPITOPO CELULAR CD8{SUP,+}-T, Y UN PROCEDIMIENTO PARA LA OBTENCION DE TAL CONJUGADO. ADEMAS TAMBIEN TRATA LA INVENCION DE LA UTILIZACION DE ESTE CONJUGADO.
ES95933299T 1994-09-30 1995-09-26 Conjugado para la induccion de la inmunidad celular. Expired - Lifetime ES2187576T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4435086A DE4435086C1 (de) 1994-09-30 1994-09-30 Konjugat zur Induktion zellulärer Immunität

Publications (1)

Publication Number Publication Date
ES2187576T3 true ES2187576T3 (es) 2003-06-16

Family

ID=6529686

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95933299T Expired - Lifetime ES2187576T3 (es) 1994-09-30 1995-09-26 Conjugado para la induccion de la inmunidad celular.

Country Status (8)

Country Link
EP (1) EP0783324B1 (es)
JP (1) JPH10506397A (es)
AT (1) ATE228857T1 (es)
DE (2) DE4435086C1 (es)
DK (1) DK0783324T3 (es)
ES (1) ES2187576T3 (es)
PT (1) PT783324E (es)
WO (1) WO1996010424A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4435086C1 (de) * 1994-09-30 1995-08-10 Wolfgang Willi Prof Dr Deppert Konjugat zur Induktion zellulärer Immunität

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4435086C1 (de) * 1994-09-30 1995-08-10 Wolfgang Willi Prof Dr Deppert Konjugat zur Induktion zellulärer Immunität

Also Published As

Publication number Publication date
JPH10506397A (ja) 1998-06-23
EP0783324A1 (de) 1997-07-16
DE59510498D1 (de) 2003-01-16
DK0783324T3 (da) 2003-03-24
WO1996010424A1 (de) 1996-04-11
EP0783324B1 (de) 2002-12-04
PT783324E (pt) 2003-04-30
DE4435086C1 (de) 1995-08-10
ATE228857T1 (de) 2002-12-15

Similar Documents

Publication Publication Date Title
ES2191152T3 (es) Terapia combinada para el tratamiento de psicosis.
ES2186018T3 (es) Procedimiento para preparar tolterodina.
ES2182906T3 (es) Grapa quirurgica helicoidal.
MX9101784A (es) Formulaciones,metodos y dispositivos anticonceptivos transdermicos
EA199900069A1 (ru) Вакцинная композиция против малярии
GR3031716T3 (en) Immunogens against gonadotropin releasing hormone
NZ285159A (en) Treatment of benign prostatic hyperplasia, endometriosis, prostatic carcinoma and obesity by administration of droloxifene
GR1000306B (el) Συνθεσεις περιποιησεως της επιδερμιδας.
GR3035941T3 (en) Vaccine adjuvants
ES2165122T3 (es) Nuevos derivados de amidina, su preparacion y utilizacion como medicamentos con efecto antagonista de ltb4.
DE69723888D1 (de) Gemischter Chimerismus und Toleranz
GT199800177A (es) Combinacion eficaz para el tratamiento de la impotencia .
MX9807473A (es) Procedimiento para la obtencion de aminas y aminonitrilos.
PT896534E (pt) Formulacoes para injeccao de avermectinas e milbemicinas a base de oleo de ricino
UY26297A1 (es) Vacuna
DK0912192T3 (da) Administration af GM-CSF til behandling af hjernetumorer og forebyggelse af sådanne tumorers tilbagevenden
ES2175798T3 (es) Cd8 como un inhibidor del sistema inmunitario celular.
AR016981A2 (es) Polipeptidos sinteticos
DK0925069T3 (da) Anvendelse af Cetrorelix til behandling af godartet prostatahypertrofi og prostatacancer
ES2177638T3 (es) Uso de mycobacterium para el tratamiento de tumores.
ES2026481T3 (es) Un dispositivo intravaginal.
EP0533804A4 (en) Sigma binding site agents
NO972219D0 (no) Immunogenpreparater
NO964238L (no) Halofantrin-fri-base for behandling av malaria og blandinger
CO4230021A1 (es) Glicosidos esteroideos, procedimientos de uso de los mismos como agentes hipocolesterolemicos y agentes antiateroscle- roticos en mamiferos.